Summary: MAPS-sponsored therapists join CBS Boston to discuss MAPS’ first Phase 3 trial of MDMA-assisted therapy for PTSD, including details about the therapeutic process and study results. Boston-based therapist Jim Hopper, Ph.D., points out the importance of a study participant’s “inner healing intelligence” throughout the MDMA-assisted therapy sessions.
Originally appearing here.
